back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-05-05 11:50 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+7,645 vol |
7,645 | |
| Filed 2021-04-30 13:54 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$344,906
+11,037 vol $31.25 each |
11,037 | |
| Filed 2021-04-30 13:53 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,037 vol |
0 | |
| Filed 2020-10-26 13:51 Tx date 2020-10-21 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-10,009 vol |
0 | |
| Filed 2020-05-04 12:07 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
11,037 | |
| Filed 2020-05-04 12:05 Tx date 2020-04-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$181,262
+10,009 vol $18.11 each |
10,009 | |
| Filed 2020-05-04 12:03 Tx date 2020-04-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,633 vol |
0 | |
| Filed 2019-05-10 17:10 Tx date 2019-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-9,885 vol |
0 | |
| Filed 2019-05-06 15:48 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+10,633 vol |
10,633 | |
| Filed 2019-05-06 15:46 Tx date 2019-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$233,582
+9,885 vol $23.63 each |
9,885 | |
| Filed 2019-05-06 15:43 Tx date 2019-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-13,881 vol |
0 | |
| Filed 2019-05-06 15:41 Tx date 2017-09-21 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-12,803 vol |
0 | |
| Filed 2018-05-28 Tx date 2018-05-23 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-21,612 vol |
12,803 | |
| Filed 2018-05-09 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+13,881 vol |
13,881 | |
| Filed 2018-05-09 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
||
| Filed 2018-05-07 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
14,285 | |
| Filed 2018-05-07 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
||
| Filed 2018-05-07 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
||
| Filed 2018-05-04 Tx date 2018-05-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-25,406 vol |
0 | |
| Filed 2018-05-04 Tx date 2018-05-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$390,528
+21,612 vol $18.07 each |
34,415 | |
| Filed 2017-05-08 Tx date 2017-05-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+25,406 vol |
25,406 | |
| Filed 2017-05-05 Tx date 2017-05-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-16,726 vol |
||
| Filed 2017-05-05 Tx date 2017-05-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)
|
Common Shares
97 - Other
|
+12,803 vol |
||
| Filed 2017-05-05 Tx date 2017-05-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)
|
Common Shares
97 - Other
|
+12,803 vol |
||
| Filed 2017-05-05 Tx date 2017-05-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$123,676
+12,803 vol $9.66 each |
||
| Filed 2017-05-05 Tx date 2017-05-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$123,676
+12,803 vol $9.66 each |
||
| Filed 2017-05-05 Tx date 2017-05-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-12,803 vol |
||
| Filed 2017-05-05 Tx date 2017-05-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-12,803 vol |
||
| Filed 2017-05-05 Tx date 2017-05-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$123,676
+12,803 vol $9.66 each |
12,803 | |
| Filed 2017-05-05 Tx date 2017-05-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-16,726 vol |
||
| Filed 2017-05-05 Tx date 2017-05-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-16,726 vol |
0 | |
| Filed 2017-03-17 Tx date 2017-03-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-1,114 vol |
0 | |
| Filed 2017-03-17 Tx date 2017-03-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)
|
Common Shares
97 - Other
|
+2,963 vol |
16,937,431 | |
| Filed 2017-03-17 Tx date 2017-03-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,500,000 vol |
16,934,468 | |
| Filed 2017-03-17 Tx date 2017-03-14 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+500,000 vol |
14,434,468 | |
| Filed 2016-07-06 Tx date 2016-07-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,148 vol |
16,726 | |
| Filed 2016-07-06 Tx date 2016-07-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,114 vol |
1,114 | |
| Filed 2016-07-06 Tx date 2015-08-19 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-22 Tx date 2016-06-17 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$374,996
+16,726 vol $22.42 each |
17,874 | |
| Filed 2016-05-11 Tx date 2015-08-19 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$281,156
+1,148 vol $244.91 each |
1,148 | |
| Filed 2016-05-11 Tx date 2015-08-19 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,148 vol |
||
| Filed 2016-05-10 Tx date 2015-08-19 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,148 vol |
1,148 | |
| Filed 2016-05-10 Tx date 2015-08-19 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-10 Tx date 2015-08-19 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
13,934,468 | ||
| Filed 2016-05-10 Tx date 2015-08-19 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-28 Tx date 2015-08-19 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Holder: ValueAct Co-Invest Master Fund, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,059,793 | ||
| Filed 2015-08-28 Tx date 2015-08-19 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Hale, David Robert
4 - Director of Issuer
Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
14,994,261 |